Supportive Care - Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Article and Video CATEGORIES

Cancer Journey

ABOUT

Arjun Gupta, MD, Advisory Board Member, GRACE Faculty

Dr. Gupta is currently an Oncology Fellow at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

For information on Dr. Gupta see the following links -

Hopkins Medicine Kimmel Cancer Center

ASCO

Supportive Care Video Series 2019 - Chemotherapy-Induced Peripheral Neuropathy (CIPN)

dbrock

Thu, 09/19/2019 - 00:00

Author

Arjun Gupta, MD, Advisory Board Member, GRACE Faculty

We are very excited to bring to you this new program on supportive care in cancer treatment.

Arjun Gupta, MD, one of the GRACE Fellows Ambassador Program Winners for 2019 is the host of this video series, Supportive Care in Cancer Treatment. In this first video, Dr. Gupta's guest is Charles Loprinzi, MD, with the Mayo Clinic in Rochester, MN. Their topic of discussion is Chemotherapy-induced peripheral neuropathy (CIPN).

For more information, you can also visit this patient page on neuropathy. https://jamanetwork.com/journals/jamaoncology/fullarticle/2726030?resultClick=1, or view the article here:

For questions or to join the conversation, please visit https://cancergrace.org/forum.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Next Previous link

Previous Post Next Post

Article

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.